LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs

Pharmaceutical Research

Volumn 18, Issue 7, 2001, Pages 914-921

  Amin, K ^a   Ng, K Y ^b   Brown, C S ^a   Bruno, M S ^c   Heath, T D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MOVA Pharmaceutical Corporation   (Puerto Rico)

Author keywords

Drug delivery system; Liposome; Liposome stability; Low density lipoprotein

Indexed keywords

FLUOROOROTIC ACID; LIPOSOME; LOW DENSITY LIPOPROTEIN RECEPTOR; METHOTREXATE GAMMA ASPARTIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; SPARFOSIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENCY; DRUG PROTEIN BINDING; ENCAPSULATION; GROWTH INHIBITION; IC 50; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

ANIMALS; ANIONS; ANTIMETABOLITES, ANTINEOPLASTIC; ASPARTIC ACID; CELL LINE; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; DRUG DELIVERY SYSTEMS; LIPOPROTEINS, LDL; LIPOSOMES; METHOTREXATE; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPIDS; PHOSPHONOACETIC ACID; RECEPTORS, LDL;

EID: 0034860538     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010971808006     Document Type: Article

References (28)

1. Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs
2. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins
3. Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles
4. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells
5. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins
6. Serum-induced leakage of negatively charged liposomes at nanomolar lipid concentrations
7. Conjugation of apolipoprotein B with liposomes and targeting to cells in culture
8. Fluorinated pyrimidines and their nucleosides
9. Crystalline dihydropteroylglutamic acid
10. Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductase
11. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
12. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
13. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase
14. Syntheses of α- and γ-substituted amides, peptides, and esters of methotrexate and their evaluation as inhibitors of folate metabolism
15. Defective simian virus 40 genomes: Isolation and growth of individual clones
16. Isolation of Chinese hamster cell mutants defective in the receptor-mediated endocytosis of low density lipoprotein
17. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation
18. Phosphorous assay in column chromatography
19. Association of methotrexate encapsulated in negatively charged liposomes with cells at nanomolar lipid concentrations
20. Correlates of folate analog transport, pharmacokinetics and selective antitumor action
21. 2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans
22. Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins
23. Association of negatively-charged phospholipids with low-density lipoprotein (LDL) increases its uptake and the deposition of cholesteryl esters by macrophages
24. Aggregation of dimyristoylphosphatidylglycerol liposomes by human plasma low density lipoprotein
25. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
26. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein
27. Recognition of liposomes by cells: In vitro binding and endocytosis mediated by specific lipid headgroup and surface charge density
28. Liposome-based therapy of human ovarian cancer: Parameters determining potency of negatively charged and antibody-targeted liposomes